📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Lexent Bio

1.1 - Company Overview

Lexent Bio Logo

Lexent Bio

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of novel liquid biopsy technology for cancer diagnosis and treatment.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Lexent Bio

Tute Genomics Logo

Tute Genomics

HQ: United States Website
  • Description: Provider of a cloud-based clinical genome interpretation platform that rapidly analyzes and annotates personal genomes, enabling researchers and clinicians to utilize human genome data for scientific discovery and individualized treatment, incorporating proprietary machine-learning algorithms.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tute Genomics company profile →
Vanadis Diagnostics Logo

Vanadis Diagnostics

HQ: Sweden Website
  • Description: Provider of a novel non-invasive prenatal testing (NIPT) solution in development based on digital analysis of cell-free DNA.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Vanadis Diagnostics company profile →
Azitra Logo

Azitra

HQ: United States Website
  • Description: Provider of microbiome-based dermatology therapeutics and consumer products, offering bioengineered live biotherapeutic candidates ATR-12 for Netherton syndrome, ATR-04 for EGFR inhibitor-associated rash, and protein candidate ATR-01 for ichthyosis vulgaris; and a microbiome dermatology platform to develop products for skin disease treatment and skin appearance improvement; plus topical ointments and creams for dryness, redness, flakiness, and inflammation.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Azitra company profile →
BISC Global Logo

BISC Global

HQ: Belgium Website
  • Description: Provider of bioinformatics, statistics, and machine learning consulting, helping customers overcome challenges in data analysis, pipeline automation, visualization, and compute environments. Consultants work on-site or off-site, project-based or time-based, with a strong focus on communication and deliverables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BISC Global company profile →
enGene Logo

enGene

HQ: Canada Website
  • Description: Provider of biotechnological treatments for mucosal diseases by inducing therapeutic proteins.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full enGene company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Lexent Bio

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Lexent Bio

2.2 - Growth funds investing in similar companies to Lexent Bio

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Lexent Bio

4.2 - Public trading comparable groups for Lexent Bio

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Lexent Bio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Lexent Bio

What does Lexent Bio do?

Lexent Bio is a provider of novel liquid biopsy technology for cancer diagnosis and treatment.

Who are Lexent Bio's competitors?

Lexent Bio's competitors and similar companies include Tute Genomics, Vanadis Diagnostics, Azitra, BISC Global, and enGene.

Where is Lexent Bio headquartered?

Lexent Bio is headquartered in United States.

How many employees does Lexent Bio have?

Lexent Bio has 1,000 employees 🔒.

When was Lexent Bio founded?

Lexent Bio was founded in 2010 🔒.

What sector and industry vertical is Lexent Bio in?

Lexent Bio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Lexent Bio

Who are the top strategic acquirers in Lexent Bio's sector and industry

Top strategic M&A buyers and acquirers in Lexent Bio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Lexent Bio?

Top strategic M&A buyers groups and sectors for Lexent Bio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Lexent Bio's sector and industry vertical

Which are the top PE firms investing in Lexent Bio's sector and industry vertical?

Top PE firms investing in Lexent Bio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Lexent Bio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Lexent Bio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Lexent Bio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Lexent Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Lexent Bio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Lexent Bio?

The key public trading comparables and valuation benchmarks for Lexent Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Lexent Bio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Lexent Bio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Lexent Bio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Lexent Bio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Lexent Bio's' sector and industry vertical?

Access recent funding rounds and capital raises in Lexent Bio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Lexent Bio

Launch login modal Launch register modal